GIFFORD BIOSCIENCE LIMITED
Significant control: Macer John Gifford (25–50%), Andrew Gifford (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Gifford Bioscience Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Gifford Bioscience Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
GIFFORD BIOSCIENCE LIMITED is an active private limited company (company number 10602974) incorporated on 6 February 2017, registered in Solihull. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 31 March 2025, showing net assets of £276k and cash of £87k, with 9 employees on average. Net assets rose 16% on the prior period (£237k).
By net assets it sits in the top quarter of 2,418 comparable companies in the UK (median £1,000, upper quartile £92k).
Ownership and control
- Mr Macer John Gifford
- owns 25–50% of shares
- holds 25–50% of voting rights
- Andrew Gifford
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 6 February 20179 yrs ago
- Next accounts due
- 31 December 2026in 68 days
- Confirmation statement due
- 20 February 2027in 119 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 March 2025 | £276k | £87k | £243k | — | — | — | 9 |
| 31 March 2024 | £237k | £157k | £129k | — | — | — | 9 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Filing and accounts signals
- Net assets above zeroNet assets £276,424 at 31 March 2025
- Net assets up 10% or more on the prior period+16.5% vs prior period
- Cash at bank of £50,000 or moreCash £86,769
- Incorporated five or more years agoIncorporated 6 February 2017
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Confirmation statement duein 119 days
- Next accounts duein 68 days
- Accounts period endNet assets £276k · small accounts
- Accounts period endNet assets £237k · small accounts
- Incorporated
Similar companies in Birmingham
- MRM GORE GROUP LTDBrierley Hill · inc. Jan 2017
- ACCUNEA LTD.Kidderminster · inc. Mar 2017
- APARON LTDTamworth · inc. Nov 2016
- RESURGO GENETICS LIMITEDBromsgrove · inc. May 2017
- DISULFICAN LIMITEDWolverhampton · inc. Jun 2017
- ASK PHARMA DEVELOPMENT LIMITEDBirmingham · inc. Aug 2016
All companies incorporated on 6 February 2017 · in Feb 2017.
Reminders for GIFFORD BIOSCIENCE LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.